Anzupgo 2 % Topical Cream

RxCUI
2721172
RxNorm name
Anzupgo 2 % Topical Cream
Display name
Anzupgo 2 % Topical Cream
Full name
Anzupgo 2 % Topical Cream
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AnzupgoDELGOCITINIBLEO Pharma, Inca59bf36e-6f04-4b47-b385-8040c95f040c2026-07-10Warnings, Adverse reactionsExact identifier
rxcui: 2721172

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a59bf36e-6f04-4b47-b385-8040c95f040cAnzupgo 2 % Topical CreamPSN4These highlights do not include all the information needed to use ANZUPGO ® safely and effectively. See full prescribing information for ANZUPGO ® . ANZUPGO ® (delgocitinib) cream, for topical use Initial U.S. Approval: 202520250728
a59bf36e-6f04-4b47-b385-8040c95f040cdelgocitinib 20 MG/ML Topical Cream [Anzupgo]SBD4These highlights do not include all the information needed to use ANZUPGO ® safely and effectively. See full prescribing information for ANZUPGO ® . ANZUPGO ® (delgocitinib) cream, for topical use Initial U.S. Approval: 202520250728
a59bf36e-6f04-4b47-b385-8040c95f040cAnzupgo 2 % Topical CreamSY4These highlights do not include all the information needed to use ANZUPGO ® safely and effectively. See full prescribing information for ANZUPGO ® . ANZUPGO ® (delgocitinib) cream, for topical use Initial U.S. Approval: 202520250728